Vivos Therapeutics (VVOS) Net Shares Issued and Repurchased (2019 - 2026)

Vivos Therapeutics (VVOS) has reported Net Shares Issued and Repurchased for 8 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.1 million, down 1.29% from the prior year.
• Net Shares Issued and Repurchased was $1.1 million for Q1 2026 at Vivos Therapeutics, up from $287.0 in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $2.0 million in Q4 2022 and troughed at $287.0 in Q4 2025.
• A 5-year average of $459389.5 and a median of $185000.0 in 2022 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased surged 3208.82% in 2024 and sank 99.97% in 2025, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.0 million in 2022, then slumped by 98.28% to $34000.0 in 2023, then surged by 3208.82% to $1.1 million in 2024, then slumped by 99.97% to $287.0 in 2025, then jumped by 386829.27% to $1.1 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $1.1 million (Q1 2026), $287.0 (Q4 2025), and $1.1 million (Q4 2024), per Business Quant data.